Peters G J, Lankelma J, Kok R M, Noordhuis P, van Groeningen C J, van der Wilt C L, Meyer S, Pinedo H M
Department of Oncology, Free University Hospital, Amsterdam, The Netherlands.
Cancer Chemother Pharmacol. 1993;31(4):269-76. doi: 10.1007/BF00685670.
Concentrations of 5-fluorouracil (5-FU) and its active metabolite 5-fluoro-2'-deoxy-5'-monophosphate (FdUMP) were measured in biopsy specimens of tumor tissue, normal mucosa, metastatic liver nodules, and normal liver tissue obtained from 39 patients and in two murine colon tumors (colon 26 and colon 38) after a single injection of 5FU at a therapeutic dose (500 mg/m2 and 100 mg/kg, respectively). These data were compared with plasma concentrations. Peak plasma concentrations (300-500 microM) of 5FU were comparable in human and murine plasma. The half-life of plasma elimination (during the period from 15 to 120 min) in both mouse and man ranged from 10 to 20 min, whereas at between 2 and 8 h, plasma concentrations varied from 0.1 to 1 microM, the half-life being about 100 min. In both species, 5FU could be measured in plasma at concentrations ranging from 0.01 to 1 microM for several days after 5FU treatment. 5FU concentrations in tissue samples obtained from 14 patients were measured during the time range of 1-6 h, those in samples taken from 7 patients, during the interval of 19-27 h; and those in samples obtained from 18 patients, within the interval of 40-48 h after injection. 5FU tumor concentrations varied between 0.78-21.6, 0.44-6.1, and 0.17-10.8 mumol/kg wet wt., respectively. Some of the 48-h samples were obtained from patients who had received leucovorin plus 5FU; coadministration of leucovorin did not alter 5FU tissue concentrations. At between 4 and 48 h, the tissue concentration/plasma concentration ratio was at least 10. 5FU concentrations in murine tumors were measured for up to 10 days after 5FU administration, with plateau 5FU tumor concentrations being about 50 mumol/kg wet wt. in colon 38 and about 200 mumol/kg wet wt. in colon 26 at 2 h after treatment; after 4 days, values of 0.5 and 4.8 mumol/kg, respectively, were obtained and after 10 days, respective concentrations of 0.1 and 0.07 mumol/kg were detected. The FdUMP concentrations measured in colon 26 and colon 38 tumors were 214 and 46 pmol/g, respectively, at 2 h after 5FU administration, and these values subsequently decreased to about 15 pmol/g in both tumors. In human tumors the initial FdUMP concentration ranged from 10 to 1000 pmol/g; at later time points the level of FdUMP was just above the detection limit of the assay. In liver metastases, high 5FU concentrations seemed to be related to high levels of FdUMP, which was likely of importance for the antitumor effect.(ABSTRACT TRUNCATED AT 400 WORDS)
在39例患者的肿瘤组织、正常黏膜、转移性肝结节及正常肝组织的活检标本中,以及在两只小鼠结肠肿瘤(结肠26和结肠38)中,单次注射治疗剂量的5-氟尿嘧啶(5-FU)(分别为500mg/m²和100mg/kg)后,测量了5-FU及其活性代谢产物5-氟-2'-脱氧-5'-单磷酸(FdUMP)的浓度。将这些数据与血浆浓度进行比较。5-FU的血浆峰值浓度(300 - 500μM)在人和小鼠血浆中相当。小鼠和人的血浆消除半衰期(在15至120分钟期间)为10至20分钟,而在2至8小时之间,血浆浓度在0.1至1μM之间变化,半衰期约为100分钟。在两个物种中,5-FU治疗后数天内,血浆中均可检测到浓度范围为0.01至1μM的5-FU。在1至6小时的时间范围内测量了14例患者组织样本中的5-FU浓度,在19至27小时的间隔内测量了7例患者样本中的浓度,在注射后40至48小时的间隔内测量了18例患者样本中的浓度。5-FU肿瘤浓度分别在湿重0.78 - 21.6、0.44 - 6.1和0.17 - 10.8μmol/kg之间变化。48小时的一些样本来自接受亚叶酸加5-FU治疗的患者;亚叶酸的联合给药未改变5-FU组织浓度。在4至48小时之间,组织浓度/血浆浓度比至少为10。在5-FU给药后长达10天测量了小鼠肿瘤中的5-FU浓度,治疗后2小时,结肠38中5-FU肿瘤浓度的稳定水平约为50μmol/kg湿重,结肠26中约为200μmol/kg湿重;4天后,分别获得0.5和4.8μmol/kg的值,10天后,检测到的浓度分别为0.1和0.07μmol/kg。在5-FU给药后2小时,结肠26和结肠38肿瘤中测量的FdUMP浓度分别为214和46pmol/g,随后这两个肿瘤中的这些值均降至约15pmol/g。在人类肿瘤中,初始FdUMP浓度范围为10至1000pmol/g;在随后的时间点,FdUMP水平略高于检测限。在肝转移灶中,高5-FU浓度似乎与高水平的FdUMP相关,这可能对抗肿瘤作用很重要。(摘要截断于400字)